Want to jump straight to the best? Most of our users prefer Interactive Brokers for stock trading.
Pfizer could rake in $19 billion from the COVID-19 vaccine in 2021. The company will generate income from the vaccine in the coming years because shot effectiveness may only work in individuals for a year or two. Don’t forget that the company has 92 drugs in clinical trials for oncology, rare diseases, vaccines, inflammation, immunology and more.
These strong results have pushed Pfizer’s stock prices higher, which may create an opportunity for investors as trials continue. If you’re considering investing in Pfizer stock but don’t know how to begin, our guide will help you learn more, choose a broker and invest in your first set of shares.
How to Buy Pfizer (NYSE: PFE) Stock
Whether you’re buying stocks under $20 to day trade or you’re looking for more expensive long-term investments, you’ll follow the same process to buy most types of stock. Let’s take a look at how to get started investing.
- Pick a Brokerage
As a retail investor, you cannot buy and sell shares of stock directly from the companies offering them. However, you can easily access the market through an online broker, which can then buy and sell shares of stock on your behalf, according to directions from you.
Dozens of brokers offer access to the world’s markets online.
- Decide How Many Shares You Want
After you open your brokerage account, fund your account with the amount of money that you want to invest. Take a look at the current share price of the stock you want to buy and how prices are trending. Calculate how many shares you’re interested in purchasing using the current market price as a guide. Remember, there is no guarantee that your investment will increase in value — so never invest more money than you can comfortably afford to lose.
- Choose Your Order Type
After you decide how many shares of stock you’d like to buy, it’s time to choose your order type. There are multiple types of orders you can place through your broker, and the order type you choose may dictate how quickly your order is filled and how much you’ll pay for each share of stock. Let’s take a look at a few key terms and order types you should know before you invest.
- Execute Your Trade
After you’ve placed your order through your brokerage platform, sit back and relax — your broker will fill the order as the order type you’ve chosen specified. If you set a limit order that cannot be filled, the broker may cancel the order at the end of the day. You’ll usually receive a notification on your platform or by email when your order is filled.
Best Online Brokers
If you don’t already have a brokerage account, consider a few of the best brokers we recommend below.
Webull, founded in 2017, is a mobile app-based brokerage that features commission-free stock and exchange-traded fund (ETF) trading. It’s regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).
Webull offers active traders technical indicators, economic calendars, ratings from research agencies, margin trading and short-selling. Webull’s trading platform is designed for intermediate and experienced traders, although beginning traders can also benefit.
Webull is widely considered one of the best Robinhood alternatives.
- Active traders
- Intermediate traders
- Advanced traders
- No account maintenance fees or software platform fees
- No charges to open and maintain an account
- Intuitive trading platform with technical and fundamental analysis tools
- Does not support trading in mutual funds, bonds or OTC stocks
SoFi’s mission is simple: to help reach clients like you reach their financial independence and realize their ambitions. SoFi knows that this independence comes from making decisions that help your money start to work for you in the long run. The brand helps individuals make these decisions through personal financial products such as personal loans, student loans and automated and active investing.
The brand additionally provides in-person experiences such as educational and networking events, personalized guidance from experienced financial planners and one-on-one advising with professional career coaches. SoFi’s services have been highlighted in outlets such as Forbes, Medium, and CNBC’s Make It.
- IPO Investing
- Mobile Investing
- U.S.-based customer service
- Highly-rated mobile app for iPhone and Android
- Only available in the U.S.
Moomoo is a commission-free mobile trading app available on Apple, Google and Windows devices. A subsidiary of Futu Holdings Ltd., it’s backed by venture capital affiliates of Matrix, Sequoia, and Tencent (NASDAQ: FUTU). Securities offered by Futu Inc., regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).
Moomoo is another great alternative for Robinhood. This is an outstanding trading platform if you want to dive deep into smart trading. It offers impressive trading tools and opportunities for both new and advanced traders, including advanced charting, pre and post-market trading, international trading, research and analysis tools, and most popular of all, free Level 2 quotes.
Get started right away by downloading Moomoo to your phone, tablet or another mobile device.
- Cost-conscious traders
- Active and Advanced traders
- Over 8,000 different stocks that can be sold short
- Access trading and quotes in pre-market (4 a.m. to 9:30 a.m. ET) and post-market hours (4 p.m. to 8 p.m. ET)
- No minimum deposit to open an account.
- No chat support
eToro is a broker that offers access to over 25 of the world’s most popular cryptocurrencies, forex and over 1600 stocks. They have a few unique education and useability tools. Traders can begin buying and selling in as little as 10 minutes.
eToro’s unique CopyTrader feature allows new investors to “copy” the buy and sell orders of professional investors, while the company’s eToro Club feature provides investors with a range of additional education tools and resources.
- Traders looking for an easy-to-use platform
- Traders who want to practice their trades using a virtual account before entering the market
- Simple platform that is easy to master
- CopyTrader feature that allows new traders to copy the same strategies used by professionals
- Virtual dummy account that gives you $100,000 to practice trades
- High non-trading fees
E*TRADE is an online discount trading house that offers brokerage and banking services to individuals and businesses. One of the first brokers to embrace online trading, E*TRADE not only survived both the dot-com bubble and Recession — it thrived. You can choose from two different platforms (one basic, one advanced). E*TRADE is a suitable broker for traders of most skill levels, whether you want to buy mutual funds and hold them for decades or dabble in options swing trading. E*TRADE offers a library of research and education materials to help you out.
- Active traders
- Derivatives traders
- Retirement savers
- Sophisticated trading platforms
- Wide range of tradable assets
- Exceptional customer service
- Limited currency trading
- Higher margin rates than competitors
- No paper trading on its standard platform
This latest groundbreaking technology is IBKR GlobalAnalyst, a new trading tool that helps investors compare the rate of PEG or price-earnings growth valuations and provide more immediate and comprehensive financial metrics of stocks, globally.
Recognizing that stock selection can be challenging for investors to compare the valuations of domestic and international stocks, Interactive Brokers created GlobalAnalyst to offer investors a simple, yet powerful tool to easily evaluate investment opportunities around the world.
Using GlobalAnalyst, investors can search for stocks by region, country, industry, market capitalization and currency to uncover undervalued stocks worldwide. The resulting table displays the current market and financial metrics, including the PEG Ratio. The PEG Ratio is the PE ratio divided by the three-year compound earnings growth rate, and smaller PEG Ratios typically indicate undervalued companies.
- Price earnings growth valuations
- Easily evaluate investment opportunities
The bid price shows the highest price that a buyer is willing to pay for a select share of stock. It is not an order type, but it’s important to know the current bid so you can decide how much to offer for each share.
The ask price is the lowest price that someone who owns the stock you want to buy is willing to sell a single share for. Like the bid price, the ask price isn’t an order type, but knowing the current ask price can help guide you when deciding how much to offer for each share.
The spread (or bid-ask spread) is the difference between the bid price and the ask price. If you’re buying or selling generally illiquid assets, pay closer attention to the bid-ask spread — a large spread can cause you to pay more when purchasing a stock or sell it for less than you anticipated if you’re using a market order. Many illiquid stocks under $10 have larger bid-ask spreads, which can quickly cut into profits.
A limit order is a type of stock trading order that tells your broker that you want to buy a set number of shares of stock at a specific price. If you set a limit order to buy 100 shares of Pfizer stock at $40 per share, for example, your broker will only execute the order if shares of Pfizer stock can be purchased for $40 per share or less. If the price rises above $40, the order might not be executed. Limit orders impose strict pricing control but are less likely to be filled when compared to market orders.
A market order is a type of stock order that tells your broker that you want to purchase a select number of shares of stock at the current market rate. When you place a market order, you won’t need to specify a price that you want your order to be executed at because your broker will execute the order as soon as possible at whatever price the market is dictating.
Market orders are more likely to be filled than limit orders, but pricing can be variable — you could end up paying a higher price than you see on your brokerage platform as the market fluctuates.
A stop-loss order is a type of sell order that tells your broker that you want to sell a security if it falls to a certain price. Say you buy 100 shares of stock for $1. You aren’t sure if the stock will increase or decrease in price, but you can’t afford to lose more than 5% of your initial investment.
In this instance, you might place a stop-loss order at $0.95. If the price of the stock you bought falls to $0.95 per share, your broker will automatically sell your lot at $0.95 per share. Stop-loss orders help investors limit their losses if a security decreases in value after purchase.
A stop-limit order combines the features of a limit order and a stop order. A stop-limit order gives an investor control over the price of a stock they’d like to purchase over a set period of time.
Imagine that Pfizer stock is currently trading at $40 per share and showing upward momentum. An investor who places a stop-limit order to buy the stock might set a limit price of $50 and a stop price of $45. If the price of Pfizer stock moves above the stop price of $45, the order turns into a limit order that will be executed so long as each share can be purchased for less than $50. If the price rises above the limit of $50 per share, the order will not be filled.
Pfizer Stock History
Headquartered in New York City, Pfizer is among the country’s oldest pharmaceutical manufacturers, founded in 1849. Like many companies, Pfizer’s stock peaked shortly before the onset of the novel COVID-19 virus, reaching a high price of $40.51 per share on January 13, 2020. The company’s stock tumbled to $29.01 per share on March 16, as COVID-19 concerns peaked.
Pfizer’s stock has rebounded exceptionally well since the onset of COVID-19 concerns.
Interest in Pfizer stock has sharply increased since November 9, 2020, when the company announced that its experimental COVID-19 vaccination was showing up to 90% efficacy rates. The stock rose 8% on this date, peaking at a price of around $40.75 per share. The stock at publication is trading at $38.78 per share following a sell-off beginning on November 10.
Pros to Buying Pfizer Stock
Many investors are keeping their eyes on Pfizer for the company’s experimental COVID-19 vaccination. Although the vaccine isn’t likely to be available to the general public before multiple new rounds of testing are completed, results of preliminary tests are showing 90% efficacy rates, well above the FDA’s threshold of 50% efficacy for COVID-19 vaccination candidates.
The company has announced that it plans to manufacture up to 50 million doses of the vaccine in 2020 and up to 1.3 billion doses in 2021 if the company’s emergency application with the FDA is approved.
The global COVID-19 pandemic has had a major effect on the market as well as the health and safety of millions of men and women around the world. An approved emergency application and patent could cause Pfizer’s stock to skyrocket.
Cons to Buying Pfizer Stock
Even if the company’s emergency application is approved by the FDA (it currently has not), there is no guarantee that this will have a meaningful effect on the stock’s price. Pfizer has agreed to supply the U.S. government with doses of the vaccine at $19.50 per dose, and strong public pressure to keep the vaccination widely available may push this price down more.
Pfizer is not the only company developing a treatment for COVID-19. For example, biotech pharmaceutical company Moderna (NASDAQ: MRNA) is set to announce efficacy rates of its own trial vaccine in as little as a few weeks. Pfizer is also working on the vaccine in conjunction with BioNTech, a Turkish-German biotechnology company, which means that any profits will be split between the 2. Building hype on the initial announcement might cause the stock’s price to crash if a competitor is approved by the FDA first.
Investing in Pharmaceuticals
Unlike penny stocks under $5, Pfizer has a company history dating back more than 170 years. This means that, even if COVID-19 trials don’t move on as hoped, the stock isn’t likely to be delisted or tank anytime soon. However, it’s important to remember that every stock has the potential to decrease in value at any time — so be sure to never invest more than you can comfortably afford to lose, no matter what you’re buying.
From the Newsdesk:
- If You Invested $1,000 In Pfizer Stock One Year Ago, Here’s How Much You’d Have Now.
- At the beginning of 2020, Pfizer shares were trading at around $37. By the beginning of March, the stock was down to $33.59, after news of the coronavirus spreading in China prompted concerns about a U.S. pandemic.
- ‘Halftime Report’ Traders Shares Their Thoughts On Pfizer, Ethereum And More
- On CNBC’s “Fast Money Halftime Report,” Tiffany McGhee said Pfizer Inc. is not making crazy money from the COVID-19 vaccine, but the company has been researching COVID-19 type of vaccines for years and the pandemic allowed it to focus more on the research and learn about these types of diseases. She continues to hold the stock and she would look for opportunities to buy.
- Pfizer and BioNTech to Supply EU with 100M Additional Doses of COVID-19 vaccine COMIRNATY